Literature DB >> 19286928

Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension.

Weijuan Yao1, Amy L Firth, Richard S Sacks, Aiko Ogawa, William R Auger, Peter F Fedullo, Michael M Madani, Grace Y Lin, Naohide Sakakibara, Patricia A Thistlethwaite, Stuart W Jamieson, Lewis J Rubin, Jason X-J Yuan.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by a fibrotic thrombus persisting and obliterating the lumen of pulmonary arteries; its pathogenesis remains poorly defined. This study investigates a potential contribution for progenitor cell types in the development of vascular obliteration and remodeling in CTEPH patients. Endarterectomized tissue from patients undergoing pulmonary thromboendarterectomy was collected and examined for the structure and cellular composition. Our data show an organized fibrin network structure in unresolved thromboemboli and intimal remodeling in vascular wall tissues, characterized by smooth muscle alpha-actin (SM-alphaA)-positive cell proliferation in proximal regions (adjacent to thromboemboli) and neoangiogenesis/recanalization in distal regions (downstream from thromboemboli). Cells that are positively stained with CD34 and fetal liver kinase-1 (Flk-1) (CD34(+)Flk-1(+)) were identified in both the proximal and distal vascular tissues; a subpopulation of CD34(+)Flk-1(+)CD133(+) cells were further identified by immunostaining. Triple-positive cells are indicative of a population of putative endothelial progenitor cells or potential colony-forming units of endothelial cells. In addition, inflammatory cells (CD45(+)) and collagen-secreting cells (procollagen-1(+)) were detected in the proximal vascular wall. Some of the CD34(+) cells in CTEPH cells isolated from proximal regions were also positive for SM-alphaA. Our data indicate that putative progenitor cell types are present in the neointima of occluded vessels of CTEPH patients. It is possible that the microenvironment provided by thromboemboli may promote these putative progenitor cells to differentiate and enhance intimal remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286928      PMCID: PMC2692803          DOI: 10.1152/ajplung.90413.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  40 in total

1.  AC133, a novel marker for human hematopoietic stem and progenitor cells.

Authors:  A H Yin; S Miraglia; E D Zanjani; G Almeida-Porada; M Ogawa; A G Leary; J Olweus; J Kearney; D W Buck
Journal:  Blood       Date:  1997-12-15       Impact factor: 22.113

2.  Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension.

Authors:  K M Moser; N S Braunwald
Journal:  Chest       Date:  1973-07       Impact factor: 9.410

3.  Long-term results after thromboendarterectomy for chronic pulmonary embolism.

Authors:  T Kramm; E Mayer; M Dahm; S Guth; T Menzel; M Pitton; H Oelert
Journal:  Eur J Cardiothorac Surg       Date:  1999-05       Impact factor: 4.191

4.  Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis.

Authors:  A Ribeiro; P Lindmarker; H Johnsson; A Juhlin-Dannfelt; L Jorfeldt
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

5.  Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli.

Authors:  I M Lang; J J Marsh; M A Olman; K M Moser; D J Loskutoff; R R Schleef
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

6.  Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts.

Authors:  Megan Short; Raphel A Nemenoff; W Michael Zawada; Kurt R Stenmark; Mita Das
Journal:  Am J Physiol Cell Physiol       Date:  2003-10-15       Impact factor: 4.249

7.  Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension.

Authors:  K M Moser; C M Bloor
Journal:  Chest       Date:  1993-03       Impact factor: 9.410

8.  Evidence for circulating bone marrow-derived endothelial cells.

Authors:  Q Shi; S Rafii; M H Wu; E S Wijelath; C Yu; A Ishida; Y Fujita; S Kothari; R Mohle; L R Sauvage; M A Moore; R F Storb; W P Hammond
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

9.  Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice.

Authors:  Yanhua Hu; Zhongyi Zhang; Evelyn Torsney; Ali R Afzal; Fergus Davison; Bernhard Metzler; Qingbo Xu
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

Authors:  M Humbert; G Monti; F Brenot; O Sitbon; A Portier; L Grangeot-Keros; P Duroux; P Galanaud; G Simonneau; D Emilie
Journal:  Am J Respir Crit Care Med       Date:  1995-05       Impact factor: 21.405

View more
  30 in total

1.  Neovascularization in the pulmonary endothelium is regulated by the endosome: Rab4-mediated trafficking and p18-dependent signaling.

Authors:  Havovi Chichger; Julie Braza; Huetran Duong; Myranda Stark; Elizabeth O Harrington
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-07       Impact factor: 5.464

2.  Neovascular capacity of endothelial progenitor cells in the adult pulmonary circulation.

Authors:  Susan Majka; Diego F Alvarez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-03       Impact factor: 5.464

3.  The characteristics of endothelial progenitor cells derived from mononuclear cells of rat bone marrow in different culture conditions.

Authors:  Nana Yang; Dawei Li; Peng Jiao; Bin Chen; Shutong Yao; Hui Sang; Mingfeng Yang; Jiju Han; Ying Zhang; Shucun Qin
Journal:  Cytotechnology       Date:  2011-02-18       Impact factor: 2.058

4.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 5.  Role of epigenetics in pulmonary hypertension.

Authors:  Tara V Saco; Prasanna Tamarapu Parthasarathy; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-09       Impact factor: 4.249

6.  Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension.

Authors:  Kewal Asosingh; Samar Farha; Alan Lichtin; Brian Graham; Deepa George; Micheala Aldred; Stanley L Hazen; James Loyd; Rubin Tuder; Serpil C Erzurum
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

Review 7.  Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.

Authors:  Johannes C Grisar; Francois Haddad; Fatemeh A Gomari; Joseph C Wu
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

8.  Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats.

Authors:  Jiang Xie; Dayi Hu; Lili Niu; Suping Qu; Shenghao Wang; Shuang Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

9.  Acute lung injury but not sepsis is associated with increased colony formation by peripheral blood mononuclear cells.

Authors:  Ellen L Burnham; Meredith Mealer; Jeanette Gaydos; Susan Majka; Marc Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-20       Impact factor: 6.914

10.  Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension.

Authors:  Aiko Ogawa; Amy L Firth; Weijuan Yao; Michael M Madani; Kim M Kerr; William R Auger; Stuart W Jamieson; Patricia A Thistlethwaite; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-24       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.